BioSpace News Archive

Press Releases

Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology Annual Meeting

May 22, 2026
·
4 min read
Press Releases

Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload

May 22, 2026
·
7 min read
Press Releases

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

May 22, 2026
·
15 min read
Press Releases

Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

May 22, 2026
·
2 min read
Press Releases

Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)

May 22, 2026
·
6 min read
Press Releases

Cencora Announces Updated Fiscal Year 2026 Financial Outlook

May 22, 2026
·
5 min read
Press Releases

Medicure Announces AGM Results and Appointment of New Director

May 22, 2026
·
6 min read
Press Releases

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

May 22, 2026
·
4 min read
Press Releases

A2 Biotherapeutics Presents Safety and Efficacy Data from the EVEREST-2 Clinical Study, Including Update on the First Complete Response to CAR T-Cell Therapy in a Patient with Non-Small Cell Lung Cancer

May 22, 2026
·
6 min read
Press Releases

2026 ASCO Abstract Highlights | Innovent Announces Preliminary PoC data of IBI363 (PD-1/IL-2α-bias bispecific fusion protein) in Combination with Chemotherapy as First-line Treatment for Advanced NSCLC, Showing Encouraging Efficacy Signals and Favorable Safety

May 22, 2026
·
10 min read